Egis Gyogyszergyar

Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Basfaktiengesellschaft

Egis Gyogyszergyar Rt.

Alkaloida Vegyeszeti Gyar

Biogal Gyogyszergyar

Gyorgy Rabloczky

Andras Varro

Istvan Elekes

Laszlo Jaszlits

Maria Kuhar Nee Kurthy

Ilona Bodi

Imre Moravcsik

Tamas Hamori

Gyorgy Cseh

Sandor Elek

Jeno Korosi

Tibor Lang

Peter Matyus

Gabor Zolyomi

Zsuzsanna Lang Nee Rihmer

Judit Sarossy Nee Kincsesy

Marton Fekete

Gyula Horvath

Lajos Toldy

Endre Kasztreiner

Zoltan Zubovics

Istvan Polgari

Peter Botka

Katalin Szemeredi

Jozsef Borsi

Geza Szilagyi

Istvan Ling

Laszlo Sebestyen

Istvan Pallagi

Andrea Jednakovits

Melinda Gal

Nandor Makk

Eva Gal

Eva Bozo

Agnes Papp

Erzsebet Zara

Ferene Andrasi

Eszter Diesler

Ildiko Varga

Klara Czako

Endre Tihanyi

Gyongyi Nagy Nee Csokas

Aniko Tegdes

Aniko Miklos Nee Kovacs

Istvan Erczi

Jeno Marosfalvi

Laszlo Szatmary

Krisztina Heltai

ZSuzanne Lang Nee Rihmer

Laszlo Czollner

Sarolta Vegvari Nee Gyurki

Laszlo Szam

Judit Sarossy Nee Kincsessy

Luca Levay

Gvorgy Schmidt

Aniko Miklos

Andrea Jednakovics

Antal Simai

Gyorgy Mathe

Adrina Kiss

The invention relates to racemic or optically active 1,3,4-benzotriazepin-5(4H)-one derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said compounds for the treatment of diseases and for the preparation of pharmaceutical compositions containing the said compounds as active agent. The new compounds according to the invention correspond to the general formula (I), ##STR1## wherein R.sup.1 represents hydrogen or straight or branched chain C.sub.1-4 alkyl optionally carrying a pyridyl or a phenyl substituent;

1,3,4-benzotraizepin-5(4H)-one derivatives and process for the

Racemic or optically active new 3(2H)-pyridazinone derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said 3(2H)-pyridazinone derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The new 3(2H)-pyridazinone derivatives according to the invention correspond to the general formula (I), ##STR1##

3(2H)-pyridazinone derivatives and process for the preparation thereof

The invention is directed to 1-(2,6-Dimethyl-Phenyl-amino)-2-Dimethyl-amino-Propane and the pharmaceutical composition thereof useful for the treatment of cardiac rhythm disorders.

New alkylene diamine derivatives

This invention relates to new 1-(hydroxystyryl)-5H-2,3-benzodiazepine derivatives of the general formula (I) and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R stands for a hydrogen or halogen atom, or a C.sub.1-4 alkoxy group,

1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical

The invention relates to new substituted dihydropyridine derivatives of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.6 are as defined herein after, the racemic and optically active variants as well as mixtures thereof, furthermore the acid addition salts of these compounds, pharmaceutical compositions containing the same and a process for the preparation thereof. The compounds of the general formula (I) can be advantageously applied for the treatment of pathologically severe hypertensions, their toxicity is low and they possess an advantageous therapeutic index.

Novel dihydropyridines having calcium antagonistic and antihypertensive

This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R and R.sup.1 are identical or different and stand for a hydrogen or halogen atom, a nitro or a C.sub.1-4 alkoxy group,

3-(hydroxymethyl)-isoquinoline derivatives

The invention relates to novel pyrimido [5,4-b][1,4]oxazine derivatives of the formula (I), and the acid addition salts thereof, pharmaceutical compositions containing them and a process for their preparation. In the formula (I) ##STR1## wherein R.sup.1 stands for a C.sub.1-4 alkyl group;

Pyrimido[5,4-B][1,4]oxazine derivatives and pharmaceutical compositions

The invention relates to new aminoguanidine derivatives of the general formula (I), ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 each represent hydrogen or halogen atom, C.sub.1-4 alkyl, nitro, trifluoromethyl or C.sub.1-4 alkoxy group,

Aminoguanidine compounds, their compositions and pharmaceutical uses

Growing community of inventors

Budapest, Hungary

Gyorgy Rabloczky